SpringWorks rises after report Germany's Merck has made nearly $3.5 billion deal
ReutersApr 24, 2025 7:18 PM
** Shares of drugmaker SpringWorks Therapeutics SWTX.O rise 8.2% to $44.59
** Germany's Merck KGaA MRCG.DE is nearing a roughly $3.5 billion deal for SWTX, the Wall Street Journal reports
** Both companies have agreed on a price close to $47 per share, report says
** Up to last close, SWTX up 14% YTD
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Related Articles
Google’s AI Reset: Why Q1 Could Trigger a Valuation Rerate
TradingKey - Alphabet’s Q1 2025 results make it official, that transition into an AI-first infrastructure platform is not theoretical anymore, it’s commercial. Irrespective of a crowded generative AI race and growing scrutiny of its market dominance, Alphabet’s stack of complete AI, monetized at scaTradingKey
21 hours ago
Tesla Q1 2025 Earning Report Review: Autonomous Driving and Robotics Lead Future Growth
TradingKey - Tesla's Q1 2025 earnings results revealed short-term financial pressure, with core data lower than market expectations, and both revenue and profitability facing challenges. Against the backdrop of sales and profit pressure, Musk remains confident in Tesla's future.TradingKey
Wed, Apr 23
Alphabet Inc. (GOOGL) Q1 2025 Earnings Preview: AI Innovations Amid Regulatory Scrutiny
TradingKey - Alphabet Inc. (GOOGL) is scheduled to post Q1 2025 results on April 24, 2025, after market close. Analysts see revenue of $89.22 billion, up 11% from the year ago period, and EPS of $2.01 versus $1.89 for the comparable period a year ago.TradingKey
Wed, Apr 23
